Revance Therapeutics Inc (RVNC)

[dewophile]

I agree w DD that it is a net positive, but share your concern on pricing because RVNC right now will be selling their drug at quite a discounted price in therapeutics relative to the value proposition. But you would rather have a good drug, take market share, and then can always adjsut price down the road (perhaps once therapeutics becomes a larger percentage of total sales). JMO